| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2013-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d750997c44c1af2c4a08e89919217119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3df7bb38f7508eb45c7607e241b1a2fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e3bb68d03bfa1ce04442b196b5bd65 |
| publicationDate |
2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150056853-A |
| titleOfInvention |
Use of a tetrasubstituted pyrazolo[4,3-d]pyrimidine compound for treating diabetic nephropathy |
| abstract |
The present invention relates to a process for the preparation of 1- (2-ethoxyethyl) -5- (ethyl (methyl) amino) -7- (4-methylpyridin- (ESRD) in a patient, comprising administering to the patient a therapeutically effective amount of at least one compound selected from the group consisting of: < RTI ID = 0.0 > [4, 3-d] pyrimidine-3-carboxamide. The invention also includes administration of a pharmaceutical composition to delay progression to ESRD. - (4-methylpyridin-2-yl) amino) -N- (methylsulfonyl) -lH-pyrazolo [4 , 3-d] pyrimidine-3-carboxamide |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015202576-A1 |
| priorityDate |
2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |